Literature DB >> 6421982

Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.

L P Svedersky, C V Benton, W H Berger, E Rinderknecht, R N Harkins, M A Palladino.   

Abstract

Murine peritoneal exudate cells (PEC) treated with murine recombinant interferon-gamma (IFN-gamma) (greater than 99% estimated purity), or concanavalin A-stimulated spleen cell supernatants developed tumoricidal properties (macrophage activation factor [MAF] activity). MAF activity was found to occur with treatments of 10 U/ml IFN-gamma, and at levels as low as 1 U/ml IFN-gamma if a second signal (5 ng/ml endotoxin) was present in the MAF assay. Endotoxin (lipopolysaccharide [LPS]) alone at these levels failed to induce MAF; induction of MAF was observed at 1,000-fold greater levels. The ability of IFN-gamma to stimulate murine PEC was species specific. Various sources of materials that displayed MAF activity, including supernatants from interleukin 2-dependent cloned cytotoxic murine T lymphocyte lines that did not display detectable antiviral activity, were neutralized by antibody raised and affinity purified against recombinant IFN-gamma. Thus, IFN-gamma, although never detectable by antiviral assays, appears to be present in many lymphokine preparations and has potent macrophage activation capability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421982      PMCID: PMC2187242          DOI: 10.1084/jem.159.3.812

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  In vitro tumor cell destruction by syngeneic mouse macrophoages: methods for assaying cytotoxicity.

Authors:  K C Norbury; I J Fidler
Journal:  J Immunol Methods       Date:  1975-04       Impact factor: 2.303

2.  Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid.

Authors:  H A Chapman; J B Hibbs
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

3.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

4.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

5.  Cooperation of immune lymphoid cells with macrophages in tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

6.  Requirement for magnesium influx in activation of alveolar macrophages mediated by ionophore A23187.

Authors:  W L Hand; N L King; J D Johnson; D A Lowe
Journal:  Nature       Date:  1977-02-10       Impact factor: 49.962

Review 7.  Macrophage activation by lymphocyte mediators.

Authors:  J R David
Journal:  Fed Proc       Date:  1975-07

8.  Standardization of a sensitive and rapid assay for lymphotoxin.

Authors:  P J Eifel; S M Walker; Z J Lucas
Journal:  Cell Immunol       Date:  1975-01       Impact factor: 4.868

9.  Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

10.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

View more
  31 in total

1.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Unique properties of auranofin as a potential anti-rheumatic drug.

Authors:  M L Barrett; G P Lewis
Journal:  Agents Actions       Date:  1986-10

3.  Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.

Authors:  S Nagao; K Sato; Y Osada
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

Review 5.  The bovine papillomavirus genome and its uses as a eukaryotic vector.

Authors:  P E Stephens; C C Hentschel
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

6.  Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats.

Authors:  J A Voorthuis; B M Uitdehaag; C J De Groot; P H Goede; P H van der Meide; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

7.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.

Authors:  G I Byrne; L K Lehmann; G J Landry
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

8.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4.

Authors:  C J Sanderson; A O'Garra; D J Warren; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

10.  In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing.

Authors:  C J Morrison; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.